Bioscience Reports 2014-02-01

Analysis of the minimal specificity of caspase-2 and identification of Ac-VDTTD-AFC as a caspase-2-selective peptide substrate.

Tanja Kitevska, SarahJ Roberts, Delara Pantaki-Eimany, SarahE Boyd, FionaL Scott, ChristineJ Hawkins

Index: Biosci. Rep. , (2014)

Full Text: HTML

Abstract

Caspase-2 is an evolutionarily conserved but enigmatic protease whose biological role remains poorly understood. To date, research into the functions of caspase-2 has been hampered by an absence of reagents that can distinguish its activity from that of the downstream apoptotic caspase, caspase-3. Identification of protein substrates of caspase-2 that are efficiently cleaved within cells may also provide clues to the role of this protease. We used a yeast-based transcriptional reporter system to define the minimal substrate specificity of caspase-2. The resulting profile enabled the identification of candidate novel caspase-2 substrates. Caspase-2 cleaved one of these proteins, the cancer-associated transcription factor Runx1, although with relatively low efficiency. A fluorogenic peptide was derived from the sequence most efficiently cleaved in the context of the transcriptional reporter. This peptide, Ac-VDTTD-AFC, was efficiently cleaved by purified caspase-2 and auto-activating caspase-2 in mammalian cells, and exhibited better selectivity for caspase-2 relative to caspase-3 than reagents that are currently available. We suggest that this reagent, used in parallel with the traditional caspase-3 substrate Ac-DEVD-AFC, will enable researchers to monitor caspase-2 activity in cell lysates and may assist in the determination of stimuli that activate caspase-2 in vivo.


Related Compounds

  • Ac-Asp-Glu-Val-A...

Related Articles:

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib

2012-01-01

[Biochem. Pharmacol. 95 , 16-27, (2015)]

Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1.

2015-09-01

[Cancer Chemother. Pharmacol. 76 , 641-50, (2015)]

AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.

2015-08-01

[Am. J. Physiol. Endocrinol. Metab. 309 , E275-82, (2015)]

Discovery of novel small-molecule compounds with selective cytotoxicity for Burkitt's lymphoma cells using 3D ligand-based virtual screening.

2014-01-01

[Molecules 19(11) , 19209-19, (2014)]

Tat/HA2 Peptides Conjugated AuNR@pNIPAAm as a Photosensitizer Carrier for Near Infrared Triggered Photodynamic Therapy.

2015-07-06

[Mol. Pharm. 12 , 2444-58, (2015)]

More Articles...